People taking medications, managing chronic conditions, or undergoing medical treatment should speak with a healthcare provider before adding NAC
In addition to providing coverage of these drugs for obesity, which would be a new indication in Medicare and in most states under Medicaid, these efforts will also allow beneficiaries in participating states and Part D plans to access GLP-1s for obesity at a lower out-of-pocket cost than if they were to purchase them with cash at the direct-to-consumer prices offered by the manufacturers
GLP-1 Medication Costs and Coverage Many insurance plans require prior authorization for weight-loss prescriptions, especially for Wegovy and Zepbound
However, it is important to note that: Clinical trials have limitations in detecting rare adverse events, particularly those that may take extended periods to develop Post-marketing surveillance continues to monitor for previously unidentified safety concerns Individual case reports may emerge, but these do not establish causation without rigorous epidemiological analysis Why the question arises : The association between Wegovy and diverticulitis may be questioned because: Gastrointestinal effects : Wegovy commonly causes GI side effects including nausea, constipation, and changes in bowel habits, which might theoretically affect colonic function
References Arranz L, et al
Association between Different GLP-1 Receptor Agonists and Gastrointestinal Adverse Reactions: A Real-World Disproportionality Study Based on FDA Adverse Event Reporting System Database. Frontiers in Endocrinology, vol